Evotec is a leading life science company dedicated to discovering and developing highly effective therapeutics for patients. With a unique multimodality platform that integrates innovative technologies, data, and science, Evotec focuses on the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. The company collaborates with a vast network of partners, including all Top 20 pharmaceutical companies and over 800 biotechnology firms, academic institutions, and healthcare stakeholders. Evotec is committed to addressing currently underserved therapeutic areas such as neurology, oncology, metabolic, and infectious diseases, aiming to create a world-leading co-owned pipeline of innovative therapeutics. Operating globally with over 5,000 skilled professionals across 17 sites, Evotec fosters a collaborative environment that enhances its research and development capabilities.